Avelumab for treating metastatic Merkel cell carcinoma

  • Technology appraisal guidance
  • TA517
  • Published: 
  • Last updated: 
Download guidance (PDF)

5 Recommendations for data collection

5.1 As a condition of the positive recommendation and the managed access agreement, the company is required to collect efficacy data from the JAVELIN part B trial.